![](/img/cover-not-exists.png)
Pembrolizumab for metastatic triple-negative breast cancer (mTNBC): long-lasting responses in the phase Ib KEYNOTE-012 study
Nanda, R., Specht, J., Dees, E.C., Berger, R., Gupta, S., Geva, R., Pusztai, L., Pathiraja, K., Ray, A., Karantza, V., Buisseret, L.Volume:
72
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(17)30206-x
Date:
February, 2017
File:
PDF, 50 KB
english, 2017